Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

patient care perspectives

Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy: Predictors of Progression

Immunoglobulin A Nephropathy and Complement 3 Glomerulopathy: Predictors of Progression

patient care perspectives
By Richard Lafayette, MD, FACP

Early HER2+ Breast Cancer: How Should Pathological Responses to Neoadjuvant Therapy at the Time of Surgery Guide Decisions About Adjuvant Treatment?

Early HER2+ Breast Cancer: How Should Pathological Responses to Neoadjuvant Therapy at the Time of Surgery Guide Decisions About Adjuvant Treatment?

patient care perspectives
By Sara M. Tolaney, MD, MPH

Dermatologic Manifestations of Chronic Graft-versus-Host Disease

Dermatologic Manifestations of Chronic Graft-versus-Host Disease

patient care perspectives
By Sergio A. Giralt, MD

Quality of Life in Patients With Endometrial Cancer

Quality of Life in Patients With Endometrial Cancer

patient care perspectives
By Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS

Treat-and-Extend Intravitreal Dosing Regimens for Neovascular Age-Related Macular Degeneration

Treat-and-Extend Intravitreal Dosing Regimens for Neovascular Age-Related Macular Degeneration

patient care perspectives
By Peter K. Kaiser, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?